publication venue for
- Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors. 133:93-99. 2019
- Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method. 128:308-314. 2018
- Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation. 125:113-117. 2017
- Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship. 118:540-546. 2016
- Conventional margins not sufficient for post-prostatectomy prostate bed coverage: An analysis of 477 cone-beam computed tomography scans. 110:235-239. 2014
- Risk factors for radiotherapy incidents and impact of an online electronic reporting system. 112:199-204. 2014
- The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. 111:316-320. 2014
- Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy. 107:140-146. 2013
- Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy. 107:165-170. 2013
- The utility of e-learning to support training for a multicentre bladder online adaptive radiotherapy trial (trog 10.01-bolart). 109:165-169. 2013
- Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01). 103:293-298. 2012
- Histopathological correlation of 11C-choline PET scans for target volume definition in radical prostate radiotherapy. 99:187-192. 2011
- Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging. 97:485-487. 2010
- EORTC radiation proctitis-specific quality of life module – Pretesting in four European countries. 97:294-300. 2010
- Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. 95:191-197. 2010
- Urethral stricture following high dose rate brachytherapy for prostate cancer. 91:232-236. 2009
- Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancer. 90:389-394. 2009
- Assessing the impact of FDG-PET in the management of anal cancer. 87:376-382. 2008
- Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results. 84:128-134. 2007
- Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy. 73:33-38. 2004
- Responses of mouse lung to irradiation. 4:167-174. 1985
- Responses of mouse lung to irradiation. 3:61-68. 1985
- The impact of prostate cancer on the sex lives of men who-have-sex-with-men (MSM): A qualitative study 2015
- PROSTATE ROTATION DETERMINED FROM DAILY IN-ROOM COMPUTERISED TOMOGRAPHY (CT) IMAGES. 2008
- Clinical implementation of an adaptive radiotherapy technique for post-prostatectomy patients using cone beam CT 2007
- Localisation of fiducial markers in prostate cancer patients using electronic portal imaging (EPI) and in-room computerised tomography (CT) 2007
- Off-line adaptive radiotherapy for bladder cancer using cone beam CT (CBCT) 2007
- Simple methods to reduce dose in cone beam CT 2007
- 164 Estimated optimal versus actual utilization or radiotherapy in British Columbia in 2001 2005
- Estimated optimal versus actual utilization of radiotherapy in British Columbia in 2001 2004
- Evidence-based estimate of the appropriate radiotherapy utilization rate for cervix cancer 2004
- Patterns of androgen deprivation therapy use with radiotherapy in post-prostatectomy setting 2018